Co-administration of delamanid and tenofovir or lopinavir/ritonavir in volunteers.
Latest Information Update: 20 Aug 2012
Price :
$35 *
At a glance
- Drugs Delamanid (Primary) ; Lopinavir/ritonavir (Primary) ; Tenofovir (Primary)
- Indications HIV-1 infections; Tuberculosis
- Focus Pharmacokinetics
- 20 Aug 2012 New trial record